Azione 300529 JAFRON BIOMEDICAL CO.,LTD.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Jafron Biomedical Co.,Ltd.

Azioni

300529

CNE100002995

Prezzo di chiusura Shenzhen S.E.
Altri mercati azionari
 00:00:00 06/06/2024 		Variaz. 5gg Var. 1 gen.
27,57 CNY -0,65% Grafico intraday di Jafron Biomedical Co.,Ltd. -1,25% +24,02%
25/04 Jafron Biomedical Co.,Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
2023 Jafron Biomedical Co.,Ltd. riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!
Registrazione 100% gratuita
Jafron Biomedical Co.,Ltd. Announces Final Dividend on A Shares for 2023, Payable on 31 May 2024
Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd.'s Equity Buyback announced on July 17, 2023, has closed with 24,242,904 shares, representing 3% for CNY 500 million.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 15 million in funding from Jafron Biomedical Co.,Ltd.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan.
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022
Jafron Biomedical Co.,Ltd. Approves Director Elections
Jafron Biomedical Co.,Ltd. Announces Profit Distribution Proposal for 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione 300529
  4. Notizie Jafron Biomedical Co.,Ltd.
  5. Altre lingue